Skip to main content
. 2018 Oct-Dec;34(4):450–457. doi: 10.4103/joacp.JOACP_133_18

Table 3.

Summary of intravenous use of meloxicam

Author Study Study design Intervention Patients
Christensen et al.[8] Single IV meloxicam dose, ibuprofen, or placebo after dental impaction surgery Randomized, double-blind, placebo-controlled Meloxicam 15 mg IV
Meloxicam 30 mg IV
Meloxicam 60 mg IV
Ibuprofen 400 mg PO
Placebo
n=230
Gottlieb et al.[15] Daily dose of IV meloxicam or placebo for post-bunionectomy pain control Randomized, double-blind, placebo-controlled Meloxicam 30 mg IV
Meloxicam 60 mg IV
Placebo
n=59
Rømsing et al.[35] Post-operative analgesic requirements in patients receiving local or IV meloxicam for inguinal hernia repair Randomized, double-blind Meloxicam 7.5 mg IV
Meloxicam 7.5 mg local infiltration
n=56
Bindewald and Singla[36] Patients undergoing abdominoplasty randomized to IV meloxicam or placebo every 24 h for up to three doses Randomized, double-blind, placebo-controlled Meloxicam 30 mg IV
Placebo
n=219
Berkowitz and Sharpe[37] Patients undergoing orthopedic surgeries randomized to IV meloxicam 30 mg or placebo every 24 hours up to 7 doses Randomized, double-blind, placebo-controlled Meloxicam 30 mg IV
Placebo
n=379
Melson and Boyer[38] Patients with advanced age and impaired renal function undergoing major elective surgery Randomized, double-blind, placebo-controlled Meloxicam 30 mg IV
Placebo
n=119

IV=Intravenous; PO = By mouth